Citing COVID-19 disruptions, iRadimed (NASDAQ:IRMD) is withdrawing its Q1 and FY 2020 financial guidance.
The company expects to report Q1 revenue of $8.6M to $8.7M.
Additionally, IRMD has no third-party debt or other restrictive covenants.
https://seekingalpha.com/news/3558886-iradimed-pulls-back-2020-guidance-amid-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.